MY123310A - Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions - Google Patents
Benzimidazoles, the preparation thereof and their use as pharmaceutical compositionsInfo
- Publication number
- MY123310A MY123310A MYPI99002822A MYPI9902822A MY123310A MY 123310 A MY123310 A MY 123310A MY PI99002822 A MYPI99002822 A MY PI99002822A MY PI9902822 A MYPI9902822 A MY PI9902822A MY 123310 A MY123310 A MY 123310A
- Authority
- MY
- Malaysia
- Prior art keywords
- general formula
- compounds
- group
- valuable
- benzimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
THE PRESENT INVENTION RELATES TO NEW BENZIMIDAZOLES OF GENERAL FORMULA (I) WHEREIN Ra TO Rc,A,Ar AND B ARE DEFINED AS IN CLAIM 1, THE TAUTOMERS, THE STEREOISOMERS, THE MIXTURES THEREOF THE PRODRUGS, THE DERIVATIVES THEREOF WHICH CONTAIN A GROUP WHICH IS NEGATIVELY CHARGED UNDER PHYSIOLOGICAL CONDITIONS, INSTEAD OF A CARBOXY GROUP, AND THE SALTS THEREOF, PARTICULARLY THE PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF WITH INORGANIC OR ORGANIC ACIDS OR BASES, WHICH HAVE VALUABLE PROPERTIES.THE COMPOUNDS OF THE ABOVE GENERAL FORMULA I WHEREIN Rc DENOTES A CYANO GROUP ARE VALUABLE INTERMEDIATES FOR PREPARING THE OTHER COMPOUNDS OF GENERAL FORMULA I, AND THE COMPOUNDS OF THE ABOVE GENERAL FORMULA I WHEREIN Rc DENOTES ONE OF THE AMIDINO GROUP METIONED IN CLAIM 1 WHICH HAVE VALUABLE PHARMACOLOGICAL PROPERTIES, PARTICULARLY AN ANTITHROMBITIC ACTIVITY.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998129964 DE19829964A1 (en) | 1998-07-04 | 1998-07-04 | New benzimidazolyl amidine or nitrile compounds, used as thrombin inhibitors, antithrombotic agents or intermediates |
DE1998157202 DE19857202A1 (en) | 1998-12-11 | 1998-12-11 | New benzimidazolyl amidine or nitrile compounds, useful as thrombin inhibitors or antithrombotic agents, for treating deep leg vein thrombosis |
DE1999112690 DE19912690A1 (en) | 1999-03-20 | 1999-03-20 | New benzimidazolyl amidine or nitrile compounds, useful as thrombin inhibitors or antithrombotic agents, for treating deep leg vein thrombosis |
Publications (1)
Publication Number | Publication Date |
---|---|
MY123310A true MY123310A (en) | 2006-05-31 |
Family
ID=27218486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI99002822A MY123310A (en) | 1998-07-04 | 1999-07-05 | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1095025B1 (en) |
JP (1) | JP4224215B2 (en) |
KR (1) | KR20010083087A (en) |
CN (1) | CN1152866C (en) |
AR (1) | AR019222A1 (en) |
AT (1) | ATE229511T1 (en) |
AU (1) | AU763094C (en) |
BG (1) | BG105111A (en) |
BR (1) | BR9911826A (en) |
CA (1) | CA2337804C (en) |
CO (1) | CO5080729A1 (en) |
DE (1) | DE59903765D1 (en) |
DK (1) | DK1095025T3 (en) |
EA (1) | EA003947B1 (en) |
EE (1) | EE04236B1 (en) |
ES (1) | ES2188192T3 (en) |
HK (1) | HK1036976A1 (en) |
HR (1) | HRPK20010007B1 (en) |
HU (1) | HUP0200710A3 (en) |
ID (1) | ID26774A (en) |
IL (1) | IL140060A0 (en) |
MX (1) | MXPA00012819A (en) |
MY (1) | MY123310A (en) |
NO (1) | NO20010028L (en) |
NZ (1) | NZ509625A (en) |
PE (1) | PE20000754A1 (en) |
PL (1) | PL345852A1 (en) |
PT (1) | PT1095025E (en) |
SK (1) | SK283744B6 (en) |
TR (1) | TR200100148T2 (en) |
TW (1) | TWI248435B (en) |
UA (1) | UA70951C2 (en) |
WO (1) | WO2000001704A2 (en) |
YU (1) | YU84700A (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19907813A1 (en) * | 1999-02-24 | 2000-08-31 | Boehringer Ingelheim Pharma | Substituted bicyclic heterocycles, their preparation and their use as pharmaceuticals |
AR023510A1 (en) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | A TEAM OF PARTS, PHARMACEUTICAL FORMULATION AND USE OF A THROMBIN INHIBITOR. |
US6451832B2 (en) | 1999-12-23 | 2002-09-17 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
DE19962329A1 (en) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates |
EP1193248A1 (en) * | 2000-09-30 | 2002-04-03 | Aventis Pharma Deutschland GmbH | Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7169934B2 (en) | 2002-06-20 | 2007-01-30 | Boehringer Ingelheim International Gmbh | (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
DE10227666A1 (en) * | 2002-06-20 | 2004-01-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | (R) -2- (4-amidinophenylaminomethyl) -1-methyl-5- [1- (carboxymethylamino) -1- (pyrrolidinocarbonyl) ethyl] benzimidazole, its monohydrochloride, process for its preparation and use as a medicament |
DE10227668A1 (en) * | 2002-06-20 | 2004-01-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicines for the treatment of systemic inflammatory response syndrome |
AU2002368133A1 (en) * | 2002-07-29 | 2004-02-16 | Shizuoka Coffein Co., Ltd. | 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis |
CN100513398C (en) | 2002-12-03 | 2009-07-15 | Axys药物公司 | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
PE20040804A1 (en) | 2002-12-19 | 2004-12-31 | Boehringer Ingelheim Pharma | CARBOXAMID DERIVATIVES AS INHIBITORS OF THE Xa FACTOR |
DE10359797A1 (en) | 2003-12-19 | 2005-07-21 | Bayer Chemicals Ag | Process for the preparation of N, N'-carbonyldiazoles |
US7371743B2 (en) | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
DE102004027821A1 (en) * | 2004-06-08 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Benzimidazoles, process for their preparation and their use as medicaments |
EP1609784A1 (en) * | 2004-06-25 | 2005-12-28 | Boehringer Ingelheim Pharma GmbH & Co.KG | Process for the preparation of 4-(benzimidazolylmethylamino)-benzamidines |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
DE102005061623A1 (en) | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Improved process for the preparation of 4- (benzimidazolylmethylamino) -benzamidines and their salts |
DE102005061624A1 (en) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Improved process for the preparation of salts of 4- (benzimidazolylmethylamino) -benzamidines |
EP2364313B1 (en) | 2008-09-09 | 2014-01-08 | Boehringer Ingelheim International GmbH | Aza-benzimidazolone chymase inhibitors |
US20110301192A1 (en) * | 2008-10-01 | 2011-12-08 | The Regents Of The University Of California | Inhibitors of Cyclin Kinase Inhibitor p21 |
JP5535931B2 (en) * | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | Bicyclic compound |
MX2013000803A (en) * | 2010-07-23 | 2013-10-28 | Conexios Life Sciences Pvt Ltd | Agonists of gpr40. |
WO2014068587A2 (en) * | 2012-10-29 | 2014-05-08 | Biophore India Pharmaceuticals Pvt. Ltd. | An improved process for the synthesis of dabigatran and its intermediates |
US10077251B2 (en) | 2012-10-29 | 2018-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of Dabigatran Etexilate and its intermediates |
CN103214422B (en) * | 2013-05-07 | 2015-07-15 | 南通大学 | Preparation methods and anti-cancer effect of novel substituted amido imidazolone derivatives |
CN110343089A (en) * | 2018-04-02 | 2019-10-18 | 上海美悦生物科技发展有限公司 | Benzimidazole derivative and pharmaceutical use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139357A (en) * | 1983-01-28 | 1984-08-10 | Torii Yakuhin Kk | Amidine derivative |
DE69327536T2 (en) * | 1992-10-14 | 2000-07-06 | Merck & Co., Inc. | FIBRINOGEN RECEPTOR ANTAGONISTS |
US5849759A (en) * | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
WO1998001428A1 (en) * | 1996-07-08 | 1998-01-15 | Du Pont Pharmaceuticals Company | AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN |
PE121699A1 (en) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | BICYCLE HETERO CYCLES DISSTITUTED AS INHIBITORS OF THROMBIN |
-
1999
- 1999-06-29 TW TW088110926A patent/TWI248435B/en active
- 1999-07-01 EA EA200100042A patent/EA003947B1/en not_active IP Right Cessation
- 1999-07-01 DK DK99932765T patent/DK1095025T3/en active
- 1999-07-01 JP JP2000558106A patent/JP4224215B2/en not_active Expired - Fee Related
- 1999-07-01 ID IDW20010009A patent/ID26774A/en unknown
- 1999-07-01 BR BR9911826-2A patent/BR9911826A/en not_active IP Right Cessation
- 1999-07-01 DE DE59903765T patent/DE59903765D1/en not_active Expired - Lifetime
- 1999-07-01 AU AU49033/99A patent/AU763094C/en not_active Ceased
- 1999-07-01 AT AT99932765T patent/ATE229511T1/en not_active IP Right Cessation
- 1999-07-01 MX MXPA00012819A patent/MXPA00012819A/en not_active IP Right Cessation
- 1999-07-01 YU YU84700A patent/YU84700A/en unknown
- 1999-07-01 PL PL99345852A patent/PL345852A1/en not_active Application Discontinuation
- 1999-07-01 HU HU0200710A patent/HUP0200710A3/en unknown
- 1999-07-01 NZ NZ509625A patent/NZ509625A/en unknown
- 1999-07-01 CA CA002337804A patent/CA2337804C/en not_active Expired - Fee Related
- 1999-07-01 UA UA2001020813A patent/UA70951C2/en unknown
- 1999-07-01 TR TR2001/00148T patent/TR200100148T2/en unknown
- 1999-07-01 CN CNB998082414A patent/CN1152866C/en not_active Expired - Fee Related
- 1999-07-01 SK SK8-2001A patent/SK283744B6/en unknown
- 1999-07-01 PT PT99932765T patent/PT1095025E/en unknown
- 1999-07-01 WO PCT/EP1999/004531 patent/WO2000001704A2/en active IP Right Grant
- 1999-07-01 EE EEP200100009A patent/EE04236B1/en not_active IP Right Cessation
- 1999-07-01 KR KR1020017000069A patent/KR20010083087A/en active IP Right Grant
- 1999-07-01 EP EP99932765A patent/EP1095025B1/en not_active Expired - Lifetime
- 1999-07-01 ES ES99932765T patent/ES2188192T3/en not_active Expired - Lifetime
- 1999-07-01 IL IL14006099A patent/IL140060A0/en unknown
- 1999-07-02 CO CO99041718A patent/CO5080729A1/en unknown
- 1999-07-02 PE PE1999000620A patent/PE20000754A1/en not_active Application Discontinuation
- 1999-07-05 MY MYPI99002822A patent/MY123310A/en unknown
- 1999-07-05 AR ARP990103241A patent/AR019222A1/en not_active Suspension/Interruption
-
2001
- 2001-01-03 BG BG105111A patent/BG105111A/en active Pending
- 2001-01-03 NO NO20010028A patent/NO20010028L/en unknown
- 2001-01-03 HR HR20000476A patent/HRPK20010007B1/en not_active IP Right Cessation
- 2001-10-15 HK HK01107199A patent/HK1036976A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY123310A (en) | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions | |
TW200504032A (en) | New carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions | |
CA2277949A1 (en) | Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions | |
DE69705829D1 (en) | META-SUBSTITUTED PHENYLSULPHONAMIDE DERIVATIVES | |
PT894084E (en) | CINAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRINE ANTAGONISTS | |
ZA200500887B (en) | Use of and some novel imidazopyridines. | |
CA2337825A1 (en) | Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions | |
CA2375259A1 (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
CA2368059A1 (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
CA2238859A1 (en) | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | |
GB9930610D0 (en) | Tricyclic vascular damaging agents | |
DK0889875T3 (en) | Cycloproylalkanoic acid derivatives | |
WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
IL137266A0 (en) | Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same | |
CA2395541A1 (en) | New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them | |
GR3036639T3 (en) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist | |
WO2000055162A3 (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
HK1052697A1 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same. | |
WO2003066594A3 (en) | 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 | |
AU6834000A (en) | Carboxylic acid amides, their production and their use as drugs | |
WO1999004770A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
DE60107832D1 (en) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
EP1174421A4 (en) | 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
DE69500156D1 (en) | Imidazopyridine derivatives and process for their preparation | |
MY140484A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |